Mainz Biomed B.V. MYNZ
Set alert
3.59 USD 0.00 0.00%
As of May 22, 12:35 PM ET
3.38 Day range 3.72
0.18 52-week range 7.95
- YTD
- +220.54%
- 1 year
- +41.34%
- Open
- 3.65
- Prev close
- 3.59
- Mkt cap
- 11.02M
- Vol
- 6.00M
- Avg vol
- 3.08M
- EPS
- -44.40
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.38
- High
- 3.72
- Forward P/E
- -6.70
- Beta
- 0.08
- Short ratio
- 0.63
- Inst. own
- 0.22%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 26, 2024
- 50-d avg
- 1.81
- 200-d avg
- 0.889895
- 1y target
- 0.00
Financial health
Altman Z-Score
-4.37 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.4×
FY 2019 5y median -28.6× FY 2025
P/S 12.5×
FY 2019 5y median 842× FY 2025
P/B 10.5×
FY 2019 5y median 232× FY 2025
P/FCF -0.6×
FY 2019 5y median -31.6× FY 2025
EV/EBITDA -0.7×
FY 2019 5y median -29.9× FY 2025
EV/Sales 15.6×
FY 2019 5y median 842× FY 2025
FCF Yield -163.5%
FY 2019 5y median -3.2% FY 2025
Profitability
Gross Margin -42.1%
FY 2019 5y median 34.4% FY 2025
Operating Margin -2513.4%
FY 2019 5y median -2513.4% FY 2025
Net Margin -3018.3%
FY 2019 5y median -2936.5% FY 2025
ROE -2526.6%
FY 2019 5y median -358.1% FY 2025
ROIC -420.1%
FY 2019 5y median -192.9% FY 2025
ROA -304.3%
FY 2019 5y median -163.5% FY 2025
Growth (YoY)
Revenue -39.9%
FY 2019 FY 2025
Operating Income 27.8%
FY 2019 FY 2025
EPS (diluted) 87.9%
FY 2019 FY 2025
Free Cash Flow 36.7%
FY 2019 FY 2025
Financial Health
Current Ratio 0.5×
FY 2019 5y median 1.3× FY 2025
Quick Ratio 0.4×
FY 2019 5y median 1.3× FY 2025
Debt / Equity 4.0×
FY 2019 5y median 0.5× FY 2025
Net Debt / EBITDA -0.1×
FY 2019 5y median 0.2× FY 2025
Interest Coverage 36.1×
FY 2019 5y median -28.7× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31